What amount sold does BACTERIN INTERNATIONAL, INC. report in Form D filings?

The latest linked filings report $4.6M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was BACTERIN INTERNATIONAL, INC.'s most recent SEC filing?

BACTERIN INTERNATIONAL, INC.'s most recent Form D filing was on 2010-06-21.

How many investors does BACTERIN INTERNATIONAL, INC. have?

The most recent Form D filing lists 7 investor(s).

What type of securities does BACTERIN INTERNATIONAL, INC. offer?

BACTERIN INTERNATIONAL, INC.'s SEC Form D filings indicate debt offerings.

BACTERIN INTERNATIONAL, INC.

CIK: 0001083672·Biotechnology·BELGRADE, MT·Corporation

Reported Sold

$4,561,000

Total Filings

Identified Offerings

Last Filed

Jun 21, 2010

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jun 21, 2010Form D — New notice

Reported sold: $1,086,000 · Target: $1,250,000

Rule 506·7 investors

Apr 14, 2010Form D/A — Amendment

Reported sold: $3,475,000 · Target: $4,000,000

Rule 506·27 investors

Changed: Reported amount sold, Reported investors

Mar 4, 2010Form D/A — Amendment

Reported sold: $3,000,000 · Target: $4,000,000

Rule 506·23 investors

Changed: Reported amount sold, Offering target, Reported investors, Sales commissions

Feb 8, 2010Form D/A — Amendment

Reported sold: $2,300,000 · Target: $3,000,000

Rule 506·17 investors

Changed: Reported amount sold, Reported investors

Jan 28, 2010Form D — New notice

Reported sold: $1,400,000 · Target: $3,000,000

Rule 506·8 investors

Fundraising Profile

Exemptions

Rule 506

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

$420,000

Amendment Rate

60%

Latest reported sold across 2 identified offerings

$4,561,000

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Guy S. Cook

Related Person

Appears on 5 filings

Mitchell T. Godfrey

Related Person

Appears on 5 filings

Kent Swanson

Related Person

Appears on 5 filings

Steve B. Warnecke

Related Person

Appears on 4 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Jun 21, 2010	New	$1,250,000	$1,086,000	7
Apr 14, 2010	Amendment	$4,000,000	$3,475,000	27
Mar 4, 2010	Amendment	$4,000,000	$3,000,000	23
Feb 8, 2010	Amendment	$3,000,000	$2,300,000	17
Jan 28, 2010	New	$3,000,000	$1,400,000	8

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Alercell Inc

Biotechnology

Offering target: $1,500,000

Filed Oct 19, 2026